FDA’s gene therapy turmoil, and an alternative model for funding research
Why did the Food and Drug Administration suddenly oust one of its top gene therapy regulators?
Related Articles
Federal judge tosses Blue Cross Blue Shield of Louisiana lawsuit, another loss for Medicare Advantage insurers
The Medicare Advantage industry has aggressively sued the federal government to overturn reduced quality ratings and keep billions of taxpayer-funded bonuses.
Ending the federal LGBTQ+ suicide prevention line is a public health failure
Ending the federal LGBTQ+ suicide prevention line is a public health failure, write two leaders in prevention and crisis response.
Fundraising in academia and the Epstein problem
Philanthropy can provide enormous benefits, and should be encouraged, but it can also create terrible reputational damage when a donor turns out to be toxic,…
There’s now a chance for bipartisan health care policies, but partisan tensions are running high
A lot stands in the way of bipartisan health care policymaking, threatening PBM reform and extenders.
Use of antibiotic to reduce STIs appears to be fueling some antibiotic resistance, research shows
The use of the antibiotic doxycycline to reduce STIs appears to be fueling some antibiotic resistance, according to new research.
FDA rejects Capricor’s cell therapy for Duchenne muscular dystrophy
The FDA rejected a Duchenne muscular dystrophy cell therapy from Capricor Therapeutics, as a larger study of the treatment continues.
Academic groups finalize counterproposal to Trump’s research overhead cuts
A coalition of academic organizations has finalized a proposed alternative to the Trump administration’s plan to cut billions of dollars in research
Ending the federal LGBTQ+ suicide prevention line is a public health failure
Ending the federal LGBTQ+ suicide prevention line is a public health failure, write two leaders in prevention and crisis response.
Trump administration cuts undocumented immigrants’ access to range of federally funded programs
HHS will limit immigrants’ access to more federally funded programs, like health clinics and head start.
Will future med students like me get the same chances I did?
Future doctors from underserved communities will have a harder time paying for med school under the new federal loan caps, one student writes.